Elexacaftor
規格
2216712-66-0CAS番号
848-534-0EC番号
N-(1,3-dimethylpyrazol-4-yl)sulfonyl-6-[3-(3,3,3-trifluoro-2,2-dimethylpropoxy)pyrazol-1-yl]-2-[(4S)-2,2,4-trimethylpyrrolidin-1-yl]pyridine-3-carboxamideIUPAC名
C26H34F3N7O4S化学式
597.7 g/mol分子量
Elexacaftor; 2216712-66-0; VX-445; RRN67GMB0V; 3-Pyridinecarboxamide, N-((1,3-dimethyl-1H-pyrazol-4-yl)sulfonyl)-6-(3-(3,3,3-trifluoro-2,2-dimethylpropoxy)-1H-pyrazol-1-yl)-2-((4S)-2,2,4-trimethyl-1-pyrrolidinyl)-; DTXSID901027907; TRIKAFTA COMPONENT ELEXACAFTOR; N-(1,3-dimethylpyrazol-4-yl)sulfonyl-6-[3-(3,3,3-trifluoro-2,2-dimethylpropoxy)pyrazol-1-yl]-2-[(4S)-2,2,4-trimethylpyrrolidin-1-yl]pyridine-3-carboxamide; N-[(1,3-dimethyl-1H-pyrazol-4-yl)sulfonyl]-6-[3-(3,3,3-trifluoro-2,2-dimethylpropoxy)-1H-pyrazol-1-yl]-2-[(4S)-2,2,4-trimethylpyrrolidin-1-yl]pyridine-3-carboxamide; N-((1,3-dimethyl-1H-pyrazol-4-yl)sulfonyl)-6-(3-(3,3,3-trifluoro-2,2-dimethylpropoxy)-1H-pyrazol-1-yl)-2-((4S)-2,2,4-trimethylpyrrolidin-1-yl)pyridine-3-carboxamide; N-(1,3-dimethylpyrazol-4-yl)sulfonyl-6-(3-(3,3,3-trifluoro-2,2-dimethylpropoxy)pyrazol-1-yl)-2-((4S)-2,2,4-trimethylpyrrolidin-1-yl)pyridine-3-carboxamide; RefChem:136490; DTXCID901513459; VX445; Elexacaftor [USAN]; N-Desmethyl Elexacaftor; UNII-RRN67GMB0V; (S)-N-((1,3-dimethyl-1H-pyrazol-4-yl)sulfonyl)-6-(3-(3,3,3-trifluoro-2,2-dimethylpropoxy)-1H-pyrazol-1-yl)-2-(2,2,4-trimethylpyrrolidin-1-yl)nicotinamide; WHO 11180; Elexacaftor (USAN); MFCD32067875; (6P)-N-(1,3-dimethyl-1H-pyrazole-4-sulfonyl)-6-[3-(3,3,3-trifluoro-2,2-dimethylpropoxy)-1H-pyrazol-1-yl]-2-[(4S)-2,2,4-trimethylpyrrolidin-1-yl]pyridine-3-carboxamide; 2229860-93-7; C26H34F3N7O4S; Elexacaftor?; N-(1,3-dimethyl-1H-pyrazole-4-sulfonyl)-6-[3-(3,3,3-trifluoro-2,2-dimethylpropoxy)-1H-pyrazol-1-yl]-2-[(4S)-2,2,4-trimethylpyrrolidin-1-yl]pyridine-3-carboxamide; N-[(1,3-Dimethyl-1H-pyrazol-4-yl)sulfonyl]-6-[3-(3,3,3-trifluoro-2,2-dimethylpropoxy)-1H-pyrazol-1-yl]-2-[(4S)-2,2,4-trimethyl-1-pyrrolidinyl]-3-pyridinecarboxamide; VX 445; WJX; ELEXACAFTOR [MI]; ELEXACAFTOR [INN]; Elexacaftor (VX-445); ELEXACAFTOR [WHO-DD]; orb1218418; orb1308463; Elexacaftor/Ivacaftor/Tezacaftor; CHEMBL4298128; SCHEMBL20239811; SCHEMBL29371083; GTPL10552; ELEXACAFTOR [ORANGE BOOK]; CHEBI:234518; MVRHVFSOIWFBTE-INIZCTEOSA-N; GLXC-23397; EX-A3637; BDBM50663478; EBC-27367; AKOS040741536; AT16051; DB15444; ELEXACAFTOR COMPONENT OF TRIKAFTA; Compound 1 [WO2018107100A1]; AC-36746; FE178668; TS-07969; HY-111772; CS-0090942; NS00133780; D11507; T14935; N-(1,3-Dimethyl-1H-pyrazole-4-sulfonyl)-6-[3-(3,3,3-trifluoro-2,2-dimethylpropoxy)-1H-pyrazol-1-yl]-2-[(4S)-2,2,4-trimethylpyrrolidin-1-yl]pyridine-3-carboxamide; N-(1,3-dimethylpyrazol-4-yl)sulfonyl-6-[3-(3,3,3-trifluoro-2,2-dimethyl-propoxy)pyrazol-1-yl]-2-[(4S)-2,2,4-trimethylpyrrolidin-1-yl]pyridine-3-carboxamide; N-[(3-Methyl-1H-pyrazol-4-yl)sulfonyl]-6-[3-(3,3,3-trifluoro-2,2-dimethylpropoxy)-1H-pyrazol-1-yl]-2-[(4S)-2,2,4-trimethyl-1-pyrrolidinyl]-3-pyridinecarboxamide; Elexacaftor Impurity;別名
Elexacaftorを含む製品
KAFTRIO 75 MG/50 MG/100 MG GRANULADO EN SOBREKAFTRIO 75 MG/50 MG/100 MG COMPRIMIDOS RECUBIERTOS CON PELICULAKAFTRIO 60 MG/40 MG/80 MG GRANULADO EN SOBREKAFTRIO 37,5 MG/25 MG/50 MG COMPRIMIDOS RECUBIERTOS CON PELICULAKAFTRIO 75 mg/50 mg/100 mg, granulés en sachetKAFTRIO 75 mg/50 mg/100 mg, comprimé pelliculéKAFTRIO 60 mg/40 mg/80 mg, granulés en sachetKAFTRIO 37,5 mg/25 mg/50 mg, comprimé pelliculéElexacaftor - Esteve QuimicaElexacaftor - SMS PharmaceuticalsElexacaftor - Laurus LabsElexacaftor - Metrochem API Private Limited
1/2ページ
Elexacaftorを販売する企業
AP
Aurobindo Pharma LimitedIndiaSE
SUZHOU EVERFORTUNE CO., LTD.China
VP
Vertex PharmaceuticalsUnited StatesVP
Vertex Pharmaceuticals (Ireland) LimitedSpainBS
BEIJING SJAR TECHNOLOGY DEVELOPMENT CO., LTD.China
MA
Metrochem API Private LimitedIndia